Mycoplasma hominis DNA (M. hominis DNA)

Mycoplasma hominis DNA represents the complete genetic material of the bacterium Mycoplasma hominis, a wall-less prokaryote associated with various urogenital and neonatal infections (StatPearls, 2023). This DNA serves as the essential template for replication and protein synthesis, processes that are vital for the pathogen's survival and proliferation within the host (Microbiology Society, 2020). In clinical pharmacology, the DNA is the indirect target of fluoroquinolone antibiotics, which act by inhibiting the enzymes DNA gyrase and topoisomerase IV, thereby preventing the proper unwinding and ligation of the DNA strands during replication (PubMed, 2021). This interference leads to the accumulation of double-strand breaks, ultimately resulting in bacterial cell death (Frontiers in Microbiology, 2019). Additionally, specific sequences within the Mycoplasma hominis DNA, such as the 16S rRNA gene, are critical targets for molecular diagnostic techniques like PCR, which allow for rapid and sensitive detection of the organism in clinical specimens (Journal of Clinical Microbiology, 2022). Monitoring mutations within this DNA is also essential for identifying emerging resistance patterns to existing antimicrobial therapies (Antimicrobial Agents and Chemotherapy, 2021).

Other names

Mycoplasma hominis genomeM. hominis deoxyribonucleic acidM. hominis genetic material

Inhibition of DNA replication and transcription through the stabilization of DNA-topoisomerase cleavage complexes, leading to lethal double-strand DNA breaks.